The predicated demise of racemic new molecular entities is an exaggeration

Nat Rev Drug Discov. 2012 Dec;11(12):972-3. doi: 10.1038/nrd3657-c1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Drug Approval*
  • Drug Discovery*
  • Stereoisomerism
  • United States
  • United States Food and Drug Administration